The market session has come to an end, and the closing bell has rung... so now it is time to go through today's biggest movers to the downside. Here are 6 of the biggest marijuana stock losers in trading on Thursday, September 14th, 2017.
Chuma Holdings, Inc. (OTC:CHUM)
Shares of Chuma Holdings, Inc. dropped 25.00% today on lower than average trading volume, closing the day at $0.0201 per share.
Cannabics Pharmaceuticals Inc. (OTC:CNBX)
Shares of Cannabics Pharmaceuticals Inc. fell 5.00% today on lower than average trading volume, closing the day at $0.95 per share.
Grow Solutions Holdings, Inc. (OTC:GRSO)
Shares of Grow Solutions Holdings, Inc. slid 14.58% on lower than average daily trading volume, closing the day at $0.041 per share.
Heliospectra AB (OTC:HLSPY)
Shares of Heliospectra AB slid 9.09% on higher than average daily trading volume, closing the day at $0.50 per share.
OWC Pharmaceutical Research Corp. (OTC:OWCP)
Shares of OWC Pharmaceutical Research Corp. sold off 7.13% on just higher than average daily trading volume, closing the day at $0.267 per share.
While it's not a stock, the cannabis-focused cryptocurrency HempCoin sold off quite a bit today following yesterdays bullish action.
Find more about today's losers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.